Research Article
EBV, HCMV, HHV6, and HHV7 Screening in Bone Marrow Samples from Children with Acute Lymphoblastic Leukemia
Table 3
Infection and prognostic factors.
| Virus | EBV+ | HCMV+ | HHV6+ | Any coinfection | (%) | 10 (14%) | 13 (19%) | 6 (9%) | 6 (9%) |
| High-risk leukemia | | | | | OR (95% IC) | 0.43 (0.12–1.57) | 0.72 (0.22–2.32) | 2.29 (0.4–15.32) | 1.12 (0.24–5.2) | | 0.29 | 0.75 | 0.4 | 1 | Relapse | | | | | OR (95% IC) | 1.19 (0.27–5.36) | 0.88 (0.20–3.82) | 1.10 (0.15–6.63) | 0.81 (0.12–4.67) | | 1 | 1 | 1 | 1 | Death | | | | | OR (95% IC) | 0.17 (0.02–1.14) | 0.16 (0.02–1.08) | 0.04 (0.04–2.81) | 0.37 (0.05–2.03) | | 0.89 | 0.08 | 0.65 | 0.41 |
|
|
OR: odds ratio; CI: confidence interval. was considered significant.
|